EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers
Top Cited Papers
Open Access
- 31 January 2008
- journal article
- research article
- Published by Elsevier BV in Journal of Thoracic Oncology
- Vol. 3 (1), 13-17
- https://doi.org/10.1097/jto.0b013e31815e8b60
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- HOXB2 as a Novel Prognostic Indicator for Stage I Lung AdenocarcinomasJournal of Thoracic Oncology, 2007
- Up-regulation of PTEN at the transcriptional level is an adverse prognostic factor in female lung adenocarcinomasLung Cancer, 2007
- Identification of the transforming EML4–ALK fusion gene in non-small-cell lung cancerNature, 2007
- Human EML4, a novel member of the EMAP family, is essential for microtubule formationExperimental Cell Research, 2006
- Two subclasses of lung squamous cell carcinoma with different gene expression profiles and prognosis identified by hierarchical clustering and non-negative matrix factorizationOncogene, 2005
- Clinical and Biological Features Associated With Epidermal Growth Factor Receptor Gene Mutations in Lung CancersJNCI Journal of the National Cancer Institute, 2005
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinibProceedings of the National Academy of Sciences of the United States of America, 2004
- EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib TherapyScience, 2004
- Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to GefitinibThe New England Journal of Medicine, 2004
- Fusion of a Kinase Gene, ALK , to a Nucleolar Protein Gene, NPM , in Non-Hodgkin's LymphomaScience, 1994